Smartphone medication adherence apps: Potential benefits to patients and providers: Response to Dayer et al

Journal of the American Pharmacists Association

Volumn 53, Issue 4, 2013, Pages 344-345

  Aungst, Timothy Dy ^a,b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b IMedicalApps LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

DOSE CALCULATION; FOOD AND DRUG ADMINISTRATION; HEALTH PRACTITIONER; HUMAN; LETTER; MEDICATION COMPLIANCE; MELANOMA; MOBILE APPLICATION; MOBILE PHONE; PHARMACIST; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; SMARTPHONE;

EID: 84890524710     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.13102     Document Type: Letter

References (17)

1. Dayer L, Heldenbrand S, Anderson P, et al. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53(2):172-81.
2. Manhattan Research. Smartphones, tablets and mobile marketing. http://manhattanresearch.com/Research-Topics/Healthcare-Professional/Mobile. Accessed May 20, 2013.
3. Fox S, Duggan M. Mobile health 2012. http://pewinternet.org/Reports/2012/ Mobile-Health/Key-Findings.aspx. Accessed May 20, 2013.
4. Apple. iTunes: RxmindMe prescription/medicine reminder and pill tracker. https://itunes.apple.com/us/app/rxmindme-pre-scription-medicine/id379864173?mt= 8. Accessed May 20, 2013.
5. Trademarkia. RxmindMe. www.trademarkia.com/rxmindme-85452861.html. Accessed May 20, 2013.
6. Apple. iTunes: Walgreens. https://itunes.apple.com/us/app/walgreens/ id335364882?mt=8. Accessed May 20, 2013.
7. Wolf JA, Moreau J, Akilov O, et al. Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatol. 2013;149(4):422-6.
8. Ferrero NA, Morrell DS, Burkhart CN. Skin scan: a demonstration of the need for FDA regulation of medical apps on iPhone. J Am Acad Dermatol. 2013;68(3):515-6.
9. Haffey F, Brady RR, Maxwell S. A comparison of the reliability of smartphone apps for opioid conversion. Drug Saf. 2013;36(2):111-7.
10. Carter T, O'Neill S, Johns N, Brady RR. Contemporary vascular smartphone medical applications [published online ahead of print, March 24, 2013]. Ann Vasc Surg.
11. Haffey F, Brady RR, Maxwell S. Smartphone apps to support hospital prescribing and pharmacology education: a review of current provision [published online ahead of print, March 12, 2013]. Br J Clin Pharmacol.
12. McCartney M. How do we know whether medical apps work? BMJ. 2013;346:f1811.
13. Quinn CC, Shardell MD, Terrin ML, et al. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934-42.
14. Food and Drug Administration. Draft guidance for industry and Food and Drug Administration staff: mobile medical applications. www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm263280.htm. Accessed May 20, 2013.
15. Happtique. App certification. www.happtique.com/app-certification/? hsCtaTracking=5598ffb3-dab4-4633-a614-0c69b3719d88%7C7b6f78f2-cb47-4ba5-8279- 65eec122c248. Accessed May 20, 2013.
16. Sanofi. iBGStar. www.ibgstar.us. Accessed May 20, 2013
17. AliveCor Inc. AliveCor. www.alivecor.com. Accessed May 20, 2013.